Soroepidemiologia retrospectiva do HIV-1

Amostras de soro de grupos populacionais dos Estados do Pará e Goiás, coletados entre 1974 e 1980, foram testadas (ELISA, imunofluorescência e immunoblot) para a presença de anticorpos contra o vírus da imunodeficiência humana tipo-1 (HIV-1). O objetivo principal foi de se mapear epidemiologicamente a ocorrência deste vírus em um período anterior a detecção da presente epidemia. Quatro amostras dos índios Xicrin foram positivas pelo teste de ELISA, porém não foram confirmadas pelos demais testes. Os resultados negativos sugerem a ausência de circulação do HIV-1, nos grupos testados, no período pré-1980.

Inversão gravimétrica estável do relevo da base e da variação da densidade com a profundidade em aterros sanitários

O presente trabalho apresenta um método que utiliza uma função hiperbólica para descrever o decaimento do contraste de densidade com a profundidade em aterros sanitários e lixões, e consiste de duas abordagens: (1) o mapeamento da base de um lixão ou de um aterro sanitário conhecendo-se a anomalia gravimétrica, o contraste de densidade na superfície e o fator de decaimento do contraste de densidade com a profundidade; (2) estimação do contraste de densidade na superfície e o fator de decaimento do contraste de densidade com a profundidade a partir do conhecimento da anomalia gravimétrica e do relevo da base do lixão ou do aterro sanitário; uma variante desta última abordagem utiliza os valores conhecidos de profundidade desses ambientes para gerar a anomalia ajustada e estimar o valor do contraste de densidade na superfície e o fator de decaimento do contraste com a profundidade através da minimização da norma Euclidiana do vetor de resíduos entre as observações e o ajuste. Em ambas abordagens o modelo interpretativo é representado por um conjunto de prismas retangulares justapostos, cujas espessuras são os parâmetros a serem determinados. As soluções encontradas através das duas abordagens são estáveis devido à incorporação de informação sobre a suavidade do relevo estimado. O método foi aplicado a dados sintéticos produzidos pela simulação de aterros sanitários e lixões com até 15 m de profundidades e de relevos suaves. Os resultados das interpretações gravimétricas foram consistentes e revelaram a eficácia do método tanto na abordagem (1) como na abordagem (2). O método também foi aplicado à anomalia Bouguer residual do aterro sanitário da Fazenda Thomas, Indiana, USA, indicando que o contraste de densidade do aterro pode ou ser constante ou apresentar variação máxima de 0,09 g/cm³.

Biofungicida à base de derivados anfifílicos catiônicos de quitosana e método de obtenção do mesmo

The present invention relates to biofungicides based on cationic, amphiphilic chitosan derivatives, with increasing proportions of dodecyl groups, for use against the fungus Aspergillus flavus, and to the method for producing said biofungicides.

Processo de biorremediação de materiais sólidos contaminados com compostos orgânicos clorados, utilizando fungos basidiomicetos ligninoceluloíticos

A presente invenção trata de um processo de biorremediação de materiais sólidos contaminados com compostos orgânicos clorados, utilizando fungos basidiomicetos lignocelulolíticos caracterizado por compreender as seguintes etapas: a. produção de inóculos apresentando uma ou mais espécies de fungos basidiomicetos lignocelulolíticos.

Environmental and genetic effects on weight and visual score traits at postweaning in Suffolk sheep

This study aimed to investigate the following environmental effects in Suffolk lambing: contemporary groups, type of birth, and age of animal and age of dam at lambing on conformation (C), precocity (P), musculature (M), and body weight at postweaning (W), and the heritability coefficients and genetic correlations among these traits. Contemporary groups, type of birth, and age of animal and age of dam at lambing were significant for W. For C, all the effects studied were significant, except linear and quadratic effects of age of the animal. For P, all effects studied were significant, except the quadratic effect of age of the animal. For M, the effects of contemporary group, type of birth, and the linear effect of the age of the animal were significant. Heritability estimates were 0.07 +/- 0.03, 0.14 +/- 0.03, 0.09 +/- 0.03, and 0.11 +/- 0.03 for C, P, M, and W, respectively, indicating a positive low response for direct selection. Estimates of genetic correlations among the visual scores (C, P, and M) and W were moderate to highly favorable and positive, ranging from 0.48 to 0.90. These results indicate that selection for visual scores will increase body weight.

Determinação de fatores de correção da intensidade de limiar anaeróbio em diferentes séries de treinamento intermitente na natação

Pós-graduação em Ciências da Motricidade - IBRC

Estimativas de parâmetros genéticos e fenotípicos para características reprodutivas e de temperamento em bovinos da raça Nelore

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Estimativas de parâmetros genéticos e fenotípicos para características reprodutivas e de temperamento em bovinos da raça Nelore

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Timing of ontogenetic changes of two cranial regions in Sotalia guianensis (Delphinidae)

Despite the fact that heterochronic processes seem to be an important process determining morphological evolution of the delphinid skull, previous workers have not found allometric scaling as relevant factor in the differentiation within the genus Sotalia. Here we analyzed the skull ontogeny of the estuarine dolphin S. guianensis and investigate differential growth and shape changes of two cranial regions the neurocranium and the face in order to evaluate the relevance of cranial compartmentalization on the ontogeny of this structure. Our results show that, even though both cranial regions stop growing at adulthood, the face has higher initial growth rates than the neurocranium. The rate of shape changes is also different for both regions, with the face showing a initially higher, but rapidly decreasing rate of change, while the neurocranium shows a slow decreasing rate, leading to persistent and localized shape changes throughout adult life, a pattern that could be related to epigenetic regional factors. The pattern of ontogenetic shape change described here is similar to those described for other groups of Delphinidae and also match intra and interspecific variation found within the family, suggesting that mosaic heterochrony could be an important factor in the morphological evolution of this group. (C) 2012 Deutsche Gesellschaft fur Saugetierkunde. Published by Elsevier GmbH. All rights reserved.

Long-term sertraline treatment increases expression and decreases phosphorylation of glycogen synthase kinase-3B in platelets of patients with late-life major depression

Background: Abnormal regulation of glycogen synthase kinase 3-beta (GSK3B) activity has been implicated in the pathophysiology of mood disorders. Many pharmacological agents, including antidepressants, can modulate GSK3B. The aim of the present study was to investigate the effect of short-and long-term sertraline treatment on the expression and phosphorylation of GSK3B in platelets of patients with late-life major depression. Methods: Thirty-nine unmedicated elderly adults with major depressive disorder (MOD) were initially included in this study. The comparison group comprised 18 age-matched, healthy individuals. The expression of total and Ser-9 phosphorylated GSK3B (pGSK3B) was determined by Enzyme Immunometric Assay (EIA) in platelets of patients and controls at baseline, and after 3 and 12 months of sertraline treatments for patients only. During this period, patients were continuously treated with therapeutic doses of sertraline. GSK3B activity was indirectly estimated by calculating the proportion of inactive (phosphorylated) forms (pGSK3B) in relation to the total expression of the enzyme (i.e.. GSK3B ratio). Results: Depressed patients had significantly higher levels of pGSK3B as compared to controls (p < 0.001). Within the MDD group, after 3 months of sertraline treatment no significant changes were observed in GSK3B expression and phosphorylation state, as compared to baseline levels. However, after 12 months of treatment we found a significant increase in the expression of total GSK3B (p = 0.05), in the absence of any significant changes in pGSK3B (p = 0.12), leading to a significant reduction in GSK3B ratio (p = 0.001). Conclusions: Our findings indicate that GSK3B expression was upregulated by the continuous treatment with sertraline, along with an increment in the proportion of active forms of the enzyme. This is compatible with an increase in overall GSK3B activity, which may have been induced by the long-term treatment of late-life depression with sertraline. (C) 2012 Elsevier Ltd. All rights reserved.

Reproductive biology of the smooth butterfly ray Gymnura micrura

This study provides the first detailed information on the reproductive biology of the smooth butterfly ray Gymnura micrura. A total of 905 individuals were sampled, 377 of which were used for the reproductive study. Juveniles accounted for 75% of the sample, but all life cycle stages were present in the study area. The disc width at which 50% were mature (WD50)was estimated at 269 and 405 mm for males and females, respectively. The WD50V(based on the onset of vitellogenesis) was estimated at 359 mm. Uterine fecundity (mean +/- s.d. = 3.8 +/- 1.3; range: 16) was positively correlated with female size. A 3564% gain in mean wet mass was observed from egg to full-term embryo in utero. Size at birth ranged from 135 to 175 mm WD (19.5 to 55.0 g), with a mean of 165.1 mm WD (43.3 g). The embryo sex ratio was not significantly different from 1:1. The ovaries of pregnant females were undergoing vitellogenesis during gestation, with females ready to ovulate soon after parturition. Gymnura micrura may have an asynchronous reproductive cycle, with females reproducing continuously throughout the year.

Evaluation of serial C-reactive protein measurements after surgical treatment of pleural empyema

OBJECTIVE: Serial C-reactive protein measurements have been used to diagnose and monitor the response to therapy in patients with pneumonia and other infectious diseases. Nonetheless, the role of C-reactive protein measurement after surgical treatment for pleural empyema is not well defined. The aim of this study is to describe the behavior of C-reactive protein levels after the surgical treatment of pleural empyema and to correlate this parameter with the patient's prognosis. METHODS: We retrospectively analyzed the records of patients with pleural empyema treated by either chest-tube drainage or surgery from January 2006 to December 2008. C-reactive protein levels were recorded preoperatively and 2 and 7 days postoperatively. The clinical outcome was binary: success or failure (mortality or the need for repeated pleural intervention). RESULTS: The study group comprised fifty-two patients. The median C-reactive protein values were as follows: 146 mg/L (pre-operative), 134 mg/L (post-operative day 2), and 116 mg/L (post-operative day 7). There was a trend toward a decrease in these values during the first week after surgery, but this difference was only statistically significant on day 7 after surgery. Over the first week after surgery, the C-reactive protein values decreased similarly in both groups (successful and failed treatment). No correlation between the preoperative C-reactive protein level and the clinical outcome was found. CONCLUSIONS: We observed that, in contrast to other medical conditions, C-reactive protein levels fall slowly during the first postoperative week in patients who have undergone surgical treatment for pleural empyema. No correlation between the perioperative C-reactive protein level and the clinical outcome was observed.

Cediranib Plus FOLFOX/CAPOX Versus Placebo Plus FOLFOX/CAPOX in Patients With Previously Untreated Metastatic Colorectal Cancer: A Randomized, Double-Blind, Phase III Study (HORIZON II)

Purpose Cediranib is a highly potent inhibitor of vascular endothelial growth factor (VEGF) signaling with activity against all three VEGF receptors. HORIZON II [Cediranib (AZD2171, RECENTIN) in Addition to Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Untreated Metastatic Colorectal Cancer] assessed infusional fluorouracil, leucovorin, and oxaliplatin/capecitabine and oxaliplatin (FOLFOX/CAPOX) with or without cediranib in patients with previously untreated metastatic colorectal cancer (mCRC). Patients and Methods Eligible patients were initially randomly assigned 1:1:1 to receive cediranib (20 or 30 mg per day) or placebo plus FOLFOX/CAPOX. In an early analysis of this and two other cediranib studies (HORIZON I [Cediranib Plus FOLFOX6 Versus Bevacizumab Plus FOLFOX6 in Patients With Previously Treated Metastatic Colorectal Cancer] and HORIZON III [Cediranib Plus FOLFOX6 Versus Bevacizumab Plus FOLFOX6 in Patients With Untreated Metastatic Colorectal Cancer]), the 20-mg dose met the predefined criteria for continuation. Subsequent patients were randomly assigned 2: 1 to the cediranib 20 mg or placebo arms. Progression-free survival (PFS) and overall survival (OS) were coprimary end points. Results In all, 860 patients received cediranib 20 mg (n = 502) or placebo (n = 358). The addition of cediranib to FOLFOX/CAPOX resulted in PFS prolongation (hazard ratio [HR], 0.84; 95% CI, 0.73 to 0.98; P = .0121; median PFS, 8.6 months for cediranib v 8.3 months for placebo) but had no impact on OS (HR, 0.94; 95% CI, 0.79 to 1.12; P = .5707; median OS, 19.7 months for cediranib v 18.9 months for placebo). There were no significant differences in the secondary end points of objective response rate, duration of response, or liver resection rate. Median chemotherapy dose-intensity was decreased by approximately 10% in patients treated with cediranib. Adverse events (AEs) associated with cediranib were manageable. Conclusion Addition of cediranib 20 mg to FOLFOX/CAPOX resulted in a modest PFS prolongation, but no significant difference in OS. The cediranib AE profile was consistent with those from previous studies. Because of the lack of improvement in OS, cediranib plus an oxaliplatin-based regimen cannot be recommended as a treatment for patients with mCRC. J Clin Oncol 30:3596-3603. (C) 2012 by American Society of Clinical Oncology

Modelo de lógica difusa para estimar zonas de planificación en incendios

Máster Universitario en Sistemas Inteligentes y Aplicaciones Numéricas en Ingeniería (SIANI)